SGMO
Sangamo Therapeutics Inc
Halal Rating :
Last Price
$1.09
Last updated:
Market Cap
-
7D Change
0.93%
1 Year Change
139.72%
Company Overview
Industries
Exchange
Next Earnings Date
Sangamo Therapeutics Inc is a clinical-stage genomic medicine company. The company is focused on developing therapies using its platform technologies in genome editing, gene therapy, gene regulation, and cell therapy to treat various diseases. Their primary focus is on developing treatments for rare diseases, neurological disorders, and cancer.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $49.41m | $38.78m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Sangamo Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.